A Study of Subcutaneous Nivolumab Monotherapy With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20)

Clinical trial NCT03656718 · COMPLETED

Trial details

NCT number: NCT03656718
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neoplasms by Site

Start date: 2018-10-29
Primary completion: 2022-09-07
Enrollment: 139

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.